Maravai LifeSciences Holdings Bilan de santé
Santé financière contrôle des critères 4/6
Maravai LifeSciences Holdings possède un total de capitaux propres de $776.4M et une dette totale de $522.5M, ce qui porte son ratio d'endettement à 67.3%. Son actif total et son passif total sont $1.4B et de $671.2M.
Informations clés
67.3%
Ratio d'endettement
US$522.52m
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | US$579.75m |
| Fonds propres | US$776.41m |
| Total du passif | US$671.19m |
| Total des actifs | US$1.45b |
Mises à jour récentes de la santé financière
Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?
Oct 15
Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?
Jul 15Recent updates
Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?
Oct 15Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 29% Jump Shows Its Popularity With Investors
Jul 18Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?
Jul 15Maravai: Embedded Expectations Remain Too High Considering Economic Calculus
Jul 12RGA Investment Advisors - Maravai: Two Elite Assets With Other-Worldly Margins Wrapped In One
Jun 12Revenues Tell The Story For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) As Its Stock Soars 25%
May 14An Intrinsic Calculation For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Suggests It's 23% Undervalued
Apr 07Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable
Feb 28Revenues Working Against Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price
Dec 19Need To Know: Analysts Just Made A Substantial Cut To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Estimates
Aug 14Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 27%?
Feb 28Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 01Maravai Lifesciences temporarily reinstates Carl Hull as CEO
Oct 19Maravai LifeSciences appoints former Danaher executive as CEO
Oct 03Maravai LifeSciences Holdings GAAP EPS of $0.53 beats by $0.15, revenue of $242.73M beats by $9.51M
Aug 04Estimating The Intrinsic Value Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Jun 27Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 29Maravai Faces Skeptical Investors As Pandemic Enters New Period
Jan 27Analyse de la situation financière
Passif à court terme: Les actifs à court terme de MRVI ( $685.4M ) dépassent ses passifs à court terme ( $68.6M ).
Passif à long terme: Les actifs à court terme de MRVI ( $685.4M ) dépassent ses passifs à long terme ( $602.6M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: MRVI dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de MRVI a été réduit de 230.8% à 67.3% au cours des 5 dernières années.
Couverture de la dette: La dette de MRVI n'est pas bien couverte par le flux de trésorerie opérationnel ( 5.9% ).
Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de MRVI sur sa dette sont bien couverts par l'EBIT.